功能性表征和in-silico预测工具改善了新型胆酸载体变体的致病性预测
Ziyue Peng1,2, Xin Wang1,3, Ying Li1,4
1Human Molecular Genetics Group, National Health Commission (NHC), Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, China.
这项研究增强了胆汁酸载体变体在胆固醇性肝病 (CLD) 中的致病性预测. 整合生物信息学和功能测试可以提高CLDs的遗传诊断准确度.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 遗传学 遗传学 是一个
- 生物化学 生物化学
背景情况:
- 胆固醇性肝病 (CLD) 缺乏足够的病原性特征,阻碍了诊断和治疗.
- 准确预测胆汁酸 (BA) 载体变体对于理解CLD机制至关重要.
研究的目的:
- 改进新型胆汁酸 (BA) 载体变体在患有慢性结核病的患者中的致病性预测.
- 在中国扩大CLDs的突变谱.
主要方法:
- 在CLD队列中分析临床和遗传特征 (n=57).
- 使用in silico工具和in vitro功能测试来识别和表征BA传送器变体.
- 专注于ABCC2基因变异及其对MRP2蛋白功能的影响.
主要成果:
- 在四个BA载体基因中确定了78个独特的变异,主要在ABCC2 (73.1%).
- 使用in silico分析发现了47种新型变体,包括错误拼接和错误意义的变体.
- 试管测试揭示了34种新型ABCC2变异的功能后果,例如异常拼接,降低MRP2水平,改变糖化和有机离子运输受损.
结论:
- 综合生物信息学和实验数据的多学科方法显著增强了基于基因的CLD诊断.
- 这项研究为重新分类BA运输变异的致病性提供了基础.
- 这些发现扩大了已知的CLD突变谱,特别是在中国人群中.
更多相关视频
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:21Real Time Monitoring of Intracellular Bile Acid Dynamics Using a Genetically Encoded FRET-based Bile Acid Sensor
Published on: January 4, 2016
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Hepatic Drug Clearance: Role of Transporters
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
ABC Transporters: Exporter
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
